🔎 Trials Near Me

Početna › Prekomjerna tjelesna masa › Florida › Orlando

Kliničke studije za Prekomjerna tjelesna masa u gradu Orlando, FL

27 studija za Prekomjerna tjelesna masa traži sudionike na lokacijama u gradu Orlando i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

U tijeku regrutacijaFaza 2
  • Charter Research - Winter Park /ID# 281968, Orlando
  • Florida Institute For Clinical Research /ID# 282739, Orlando
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07752979

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

U tijeku regrutacija
  • Orlando Health, Inc., Orlando
Od 21 do 65 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07090005

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
  • Kailera Clinical Site, Orlando
Od 18 do 85 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07793929

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

U tijeku regrutacijaFaza 3
  • Florida Institute for Clinical Research, LLC, Orlando
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07533175

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

U tijeku regrutacijaFaza 2
  • Clinical Site Partners, LLC DBA Flourish Research, Winter Park · 5 mi udaljenosti
  • K2 Medical Research Maitland LLC, Main Office, Maitland · 6 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07685808

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

U tijeku regrutacijaFaza 2
  • Clinical Neuroscience Solutions, Orlando
Od 18 do 75 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT07837973

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

U tijeku regrutacijaFaza 3
  • Clinical Neuroscience Solution, Orlando
  • Florida Institute for Clinical Research, LLC, Orlando
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

U tijeku regrutacijaFaza 3
  • Florida Inst For Clin Res LLC, Orlando
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

U tijeku regrutacijaFaza 3
  • Headlands Research Orlando, Orlando
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07794579

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

U tijeku regrutacijaFaza 3
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

U tijeku regrutacijaFaza 3
  • Florida Hospital- Center for Pediatric Research, Orlando
  • Nemours Children's Health, Orlando
Od 6 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

U tijeku regrutacijaFaza 3
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

U tijeku regrutacijaFaza 3
  • Research Site, Ocoee · 10 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

U tijeku regrutacijaFaza 3
  • West Orange Endocrinology, Ocoee · 10 mi udaljenosti
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

U tijeku regrutacijaFaza 3
  • Conquest Research, Winter Park · 5 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

U tijeku regrutacijaFaza 2
  • Charter Research - Winter Park, Orlando
Od 18 do 75 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

U tijeku regrutacijaFaza 3
  • AURORA-1 Clinical Site, Winter Park · 5 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • AURORA-2 Clinical Site, Winter Park · 5 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07743450

Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households

U tijeku regrutacija
  • University of Central Florida, Orlando
Od 5 do 11 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT07464015

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

U tijeku regrutacijaFaza 3Zdravi dobrovoljci dobrodošli
  • ACCOMPLISH-2 Research Site, Ocoee · 10 mi udaljenosti
Od 18 do 79 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

U tijeku regrutacijaFaza 2
  • Charter Research - Winter Park, Orlando
Od 18 do 75 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

U tijeku regrutacijaFaza 3
  • Kailera Clinical Site, Orlando
  • Kailera Clinical Site, Orlando
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

U tijeku regrutacijaFaza 3
  • Clinical Neuroscience Solutions - Orlando, Orlando
  • Combined Research Orlando Phase I IV, Orlando
  • Florida Institute for Clinical Research, Orlando
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

U tijeku regrutacijaFaza 3
  • Florida Institute for Clinical Research, Orlando
  • Conquest Research - Winter Park, Winter Park · 5 mi udaljenosti
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

U tijeku regrutacijaFaza 3
  • Clinical Neuroscience Solutions, Orlando
  • Florida Institute for Clinical Research, Orlando
Od 18 do 99 godina · Oba spola · Ažurirano 27. kol 2026. · NCT07575399

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

U tijeku regrutacijaFaza 3
  • ACCOMPLISH-1 Research Site, Ocoee · 10 mi udaljenosti
Od 18 do 79 godina · Oba spola · Ažurirano 10. kol 2026. · NCT07654361

Studije za Prekomjerna tjelesna masa u drugim gradovima

Ostale studije u gradu Orlando

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.